Your email has been successfully added to our mailing list.

×
0 0 0.00740740740740751 0.00740740740740751 0.00705185185185186 0.00740740740740751 0.00740740740740751 0.0118518518518519
Stock impact report

Aravive up 5% on encouraging AVB-500 data [Seeking Alpha]

Aravive, Inc. (ARAV) 
Last aravive, inc. earnings: 3/27 08:00 am Check Earnings Report
Company Research Source: Seeking Alpha
Aravive up 5% on encouraging AVB-500 data Thinly traded nano cap Aravive ( ARAV 5% positive data Binding to GAS6 turns off a signaling pathway in tumor cells called AXL that plays a key role in cancer cell survival and proliferation. Patients with high-grade serous ovarian cancer with high tumor GAS6 expression (80%) experienced median progression-free survival (PFS) of 7.7 months compared to 15.2 months in patients with low tumor GAS6 expression (25 ng/mL) compared to 20.4 months in those with low serum levels of GAS6 ( Show less Read more
Impact Snapshot
Event Time:
ARAV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ARAV alerts
Opt-in for
ARAV alerts

from News Quantified
Opt-in for
ARAV alerts

from News Quantified